About Comms

This author has not yet filled in any details.
So far Comms has created 401 blog entries.

INFANT PhD student received Fellowship of the Royal College of Pathologists

By |2023-09-15T09:48:59+01:00September 12th, 2023|

Huge congratulations to INFANT PhD student Caroline Joyce on receiving her Fellowship of the Royal College of Pathologists.

Caroline’s PhD work is on the identification of Biomarkers for the Diagnosis, Management and Follow-up of Women with Gestational Trophoblastic Disease. This project aims to identify more sensitive biomarkers for GTD to allow earlier detection of disease recurrence and progression to malignant disease.

🔗 More info: Biomarkers for Gestational Trophoblastic Disease | University College Cork (ucc.ie)

This is a collaborative project between INFANT – Pregnancy Loss Research Group (PLRG) (Prof. Keelin O’Donoghue), the School of Biochemistry & Cell Biology (Prof. Tommie McCarthy) and the National Trophoblastic Disease Centre (Dr John Coulter).

Born Too Soon Airs on Virgin Media One

By |2023-09-04T09:26:20+01:00September 4th, 2023|

Born Too Soon will give an unprecedented look into lives of the hardworking staff who dedicate their lives to caring for vulnerable newborns at CUH’s neonatal unit.

TV crews have been in the hospital all year filming ‘Born Too Soon,’ following the stories of families and medical teams looking after premature babies born at the busy hospital.

At CUH, preemies are given round-the-clock care, with the new series showing the ups and downs of life looking after frail babies – particularly in a time with strict Covid restrictions.

Viewers will get to see the dedication and love put into giving babies born preterm the best chance possible when Born Too Soon starts at 9 pm Tues 5 September on Virgin Media One.

INFANT Director, Prof Geraldine Boylan wins prestigious award

By |2023-09-05T15:36:11+01:00August 31st, 2023|

Geraldine Boylan, Professor of Neonatal Physiology, Department of Paediatrics & Child Health, University College Cork and Director of the INFANT Research Centre was awarded the 2023 Tom Connor Distinguished Investigator Award from Neuroscience Ireland.

Professor Boylan was presented the prestige award at the Royal College of Surgeons Ireland (RCSI) during the annual Neuroscience Ireland conference. This conference brings together an international audience of neuroscience researchers, clinicians, and industrial partners to share knowledge and expertise, fostering the advancement of excellence in neuroscience research within Ireland.

The NSI Distinguished Investigator Award is presented every two years to an exceptional research scientist from Ireland or based on the island of Ireland who has made an exceptional contribution to the field of neuroscience. This award is given in memory of the former President of Neuroscience Ireland, Tom O’ Connor, who passed away in 2013.

Accepting the award, Professor Boylan said: “I am very honoured and humbled to receive the Tom Connor Distinguished Investigator Award from Neuroscience Ireland. This recognition for neonatal neuroscience represents the collective efforts and hard work of the research team at INFANT over many years and I am truly grateful.”

Professor John Cryan, UCC Vice President for Research and Innovation at UCC, and recipient of the award in 2017 said: “Congratulations to Professor Geraldine Boylan on receiving this prestigious award, a testament to her dedication and expertise in neuroscience research. Professor Boylan’s remarkable achievements in neuroscience exemplify the spirit of innovation that drives our institution’s research ambitions. It is also fitting to see someone of Professor Boylan’s calibre hold this award in the name of Professor Tom Connor, one of Ireland’s exceptional scientists who passed away far too soon.”

 

International Guest Speaker on Knowledge Translation and Patient Engagement in Child Health Research

By |2023-08-24T16:12:14+01:00August 24th, 2023|

INFANT Research Centre are delighted to be hosting a special guest speaker event with Dr. Shannon Scott, Professor and a Canada Research Chair in Knowledge Translation for Children’s Health from the University of Alberta, Canada on Thursday 7 September from 13.00-14.00 in room 1.02 Brookfield Health Sciences Complex.

In advance of the launch of UCC Futures: Children, and in line with the strategy of UCC to build on our reputation for excellence in the field of children’s health, rights and wellbeing, this talk would be of particular interest to researchers at all stages working in areas of child health research, knowledge translation and patient engagement.

Dr. Shannon Scott is an internationally recognised nurse, scientist, educator and knowledge translation and knowledge mobilization leader. Knowledge translation (KT) is the process of taking information from reliable evidence-based research and putting it into user-friendly form for everyone to understand and use. During this event, Dr. Scott will discuss the growing movement to involve patients in health research and share insights into her research programme “Translating Evidence in Child Health to Enhance Outcomes” (ECHO). This programme aims to develop, evaluate, and disseminate evidence-based knowledge translation (KT) tools with parents to improve health decision-making and outcomes.

She will also talk about their iterative co-development process, discuss the development of parent advisory forums and the progressive research that is focused on cultural adaptation of interventions. These research findings and experience will be of importance to anyone doing co-development research as well as those who actively and authentically involve patients in their research.

If you’re interested in attending, register HERE.  Please feel free to share event with colleagues who may also find it of interest.

Speaker Bio:

Dr. Shannon Scott is an internationally recognized nurse, scientist, educator and knowledge translation and knowledge mobilization leader. As the Canada Research Chair in Knowledge Translation for Children’s Health, Dr. Scott has improved health outcomes for children through her interdisciplinary research that merges research and the arts to develop national award-winning knowledge translation tools for Canadian families. She is a founding co-Director of Translating Emergency Knowledge for Kids (TREKK) a national initiative that is game changing for children’s emergency care. She has received more than $58,000,000 (Canadian dollars) of research funding as principal investigator and coinvestigator, published more than 200 publications and delivered more than 550 presentations around the globe.

We Are Hiring! – Post-Doctoral Researcher, INFANT Research Centre

By |2023-07-24T10:05:12+01:00July 24th, 2023|

INFANT Research Centre is now accepting applications for a Postdoctoral Researcher on a part time basis to work on COVICAT project which is supported by the North-South HEA programme. The researcher will be responsible for data management and data analysis of data on COVID-19 infection and vaccine in pregnancy in Ireland and Europe. Strong management and quantitative skills are required for the project. Expertise in time-series methods would be an advantage.

The successful candidate should have a PhD in Epidemiology, Public Health or a PhD in another related field but with strong quantitative skills.

Research Assistants with at least 3-4 years’ experience in quantitative research may also apply for this post.

Post Duration: 12 months

Salary: Post-Doctoral Researcher€42,031 – €48,427 p.a. (IUA PD1 Salary Scale), pro rata 0.6 FTE,  Research Assistant: €29,275 – €39,158 p.a. (IUA RA Salary Scale), pro rata 0.6 FTE

Project Title: COVICAT: COVID-19 infection and vaccination in pregnancy: An ecological study to assess congenital anomalies

For an information package including further details of the post see: https://t.co/wq1pQJfk3c 

Informal enquiries can be made in confidence to Dr Ali Khashan, INFANT Research Centre, Tel: + 353 (0) 21 420 5565; Email: a.khashan@ucc.ie

Applications must be submitted online via the University College Cork vacancy portal (https://ore.ucc.ie/). Queries relating to the online application process should be referred to recruitment@ucc.ie, quoting the job-title and project name.

Candidates should apply, in confidence, before 12 noon (Irish Local Time) on Thursday July 27th 2023.

No late applications will be accepted. Please note that an appointment to posts advertised will be dependent on University approval, together with the terms of the employment control framework for the higher education sector.

UCC is committed to creating and fully embracing an inclusive environment where diversity is celebrated.  As a University we strive to create a workplace that reflects the diversity of our student population where people from a wide variety of backgrounds learn from one another, share ideas, and work collaboratively. UCC is committed to being an employer that recognises the value of diversity amongst its staff.  We encourage applicants to consult our policies at https://www.ucc.ie/en/edi/policies/ and initiatives at https://www.ucc.ie/en/edi/implementation/ and we welcome applications from everyone, including those who are underrepresented in the protected characteristics set out in our Equal Opportunities & Diversity Policy.

Funded PhD Opportunity, supported by the HRB CRF (Clinical Research Facility) UCC

By |2023-07-10T15:59:06+01:00July 10th, 2023|

Funded PhD, supported by the HRB CRF (Clinical Research Facility) UCC

Project Title: PPI in clinical trials for vulnerable populations

This HRB CRF (Clinical Research Facility) UCC fully funded PhD involves a multistakeholder collaboration between CRFC, PPI Ignite Network @ UCC and the INFANT Research Centre.

The PhD will address conceptual and implementation aspects of PPI in the context of clinical trials in neonates/children. The work will be embedded within one or more ongoing CRF/UCC trials. The PhD will inform ongoing CRFC best practice implementation of PPI in clinical trials for diverse patient population groups, as well as develop the theoretical and PPI implementation competence of the successful PhD scholar.

Funding arrangement: Full time four years.

Supports: Placement in INFANT.

UCC PhD supports and training.

Supported by PPI Ignite Network @ UCC

Registration: Full time

Stipend: €19,000

The PhD will be supervised by Professor Geraldine Boylan, Professor Patricia Kearney, Site Lead PPI Ignite @ UCC and Dr Emmy Racine, Programme Manager, PPI Ignite @ UCC.

To apply please send a statement of interest (<200 words) and a brief (2 page max) CV to Professor Patricia Kearney, PPI Ignite @ UCC. Email: patricia.kearney@ucc.ie

CLOSING DATE: Thursday July 27th

CergenX, INFANT spin-out raises €1.2m in funding to develop newborn brain screening

By |2023-07-10T15:32:25+01:00July 10th, 2023|

Cork-based medtech company CergenX has raised €1.2 million in funding to further develop its technology to screen newborns for brain injury.

  • CergenX is a spin-out from the Infant Centre in UCC. Founded by chief executive Jason Mowles, chief science officer Professor Geraldine Boylan and chief technology officer Sean Griffin in 2021.
  • The company is currently developing a system that uses artificial intelligence to screen all newborns for signs of brain injury in less than 15 minutes.

The funding was raised through a private financing round, with participation from high net worth individuals and existing investor Enterprise Ireland. It brings to €2 million the total raised by the company to date.

The money will be used to support the development of the newborn brain screener, expanding its staff with roles in artificial intelligence, product management, and software engineering and accelerating the company’s path to market.

CergenX is a spin-out from the Infant Centre in UCC. Founded by chief executive Jason Mowles, chief science officer Professor Geraldine Boylan and chief technology officer Sean Griffin in 2021, the company is currently developing a system that uses artificial intelligence to screen all newborns for signs of brain injury in less than 15 minutes.

“This latest investment not only validates the immense potential of our newborn brain screener but also demonstrates the confidence our investors have in our vision,” Mr Mowles said. “These funds will enable us to complete the development of the newborn brain screener and launch the product pilots next year. This is incredibly exciting and rewarding work and we have a real opportunity to make a major difference in a vital area of newborn healthcare.”

Electroencephalography monitoring (EEG), the gold standard for assessing brain function in newborns, can be expensive and complex, with a shortage of trained specialists to interpret the results. The CergenX system allows non-specialists to carry out the screening, with algorithms helping to pinpoint potential problems with brain activity.

The company has developed a prototype device, and is targeting a 2025 release after undergoing regulatory approval.

It is estimated that at least five in every 1,000 newborn babies may have a brain injury of some degree, but it is difficult to diagnose until the child is older.

“The device will help answer a very simple but important question for medical staff which is ‘should I be worried about this baby’s brain or not?’ ” said Prof Boylan.

CergenX has identified a considerable market for the newborn brain screener, with the EU, UK, and the US among the initial targets, where there are more than 8 million births a year.

Source: CergenX raises €1.2m in funding to develop newborn brain screening – The Irish Times (Ciara O’Brien)

INFANT PI, Prof Keelin O’Donoghue awarded Distinguished Researcher Award

By |2023-08-01T13:15:38+01:00July 6th, 2023|

INFANT PI, Professor Keelin O’Donoghue was awarded the International Stillbirth Alliance (ISA) Distinguished Researcher Award for her contribution or her contribution to research on stillbirth/newborn death. The award was conferred at the closing ceremony of the 2023 conference, hosted at the University of Sheffield from 30 June to 02 July.

Announcing the award, Professor Adrienne Gordon said: “She has been awarded this on the unanimous decision by the Board to reflect her years of significant research around stillbirth, most particularly in Ireland where she is continuing to strive for best practice care for families and high quality evidence, particularly in terms of the national standards, so we thank you Keelin for all that you do.”

Professor O’Donoghue, along with 11 other members of the Pregnancy Loss Research Group, attended the International Stillbirth Alliance (ISA) Conference 2023 at The University of Sheffield from 30 June to 02 July, showcasing a variety of work undertaken by the Group in the areas of:

Source: News and media | University College Cork (ucc.ie)

Cerebral Palsy Foundation awards €1.6 million funding to UCC

By |2023-06-29T14:57:57+01:00June 6th, 2023|

Cerebral Palsy Foundation awards €1.6 million funding to University College Cork to support cerebral palsy education and research

  • Funding of €1.6 million will support UCC’s appointment of a Chair in Early Brain Injury and Cerebral Palsy.
  • The Cerebral Palsy Foundation Chair will lead research in early brain injury and cerebral palsy at the Irish Centre for Maternal and Child Health Research (INFANT), UCC.

University College Cork (UCC) and the Cerebral Palsy Foundation today announced the creation of a new Chair in Early Brain Injury and Cerebral Palsy.

The new ‘Cerebral Palsy Foundation Chair’ is made possible thanks to generous support of €1.6 million from the Cerebral Palsy Foundation, a global not-for-profit organisation committed to creating positive change for those with Cerebral Palsy and related disabilities. The appointed Chair will lead a programme of research and public engagement that will empower the voice of young children and families living with cerebral palsy.

Currently the most common lifelong physical disability acquired during childhood, cerebral palsy is diagnosed in approximately 150 children each year in Ireland. Early diagnosis in babies can lead to much better outcomes. The Cerebral Palsy Foundation’s partnership with UCC will enable researchers at INFANT to generate critical knowledge that will transform outcomes for children with Cerebral Palsy and their families.

“On behalf of UCC, I sincerely thank the Cerebral Palsy Foundation for their transformational funding. With this generous support, UCC can be a catalyst for change for people with cerebral palsy today and for future generations,” said UCC President, Professor John O’Halloran.

“The Cerebral Palsy Foundation looks forward to working with UCC and is so thankful for the funding it has received from donors to drive forward the CP Programme of Excellence in Ireland. We are excited that UCC will lead research and clinical care to change the trajectories of lives of infants with early brain injury and CP,” said Rachel Byrne, Executive Director of the Cerebral Palsy Foundation.

“I would like to sincerely thank the Cerebral Palsy Foundation for this very generous funding. We are committed to working in partnership with the Foundation to make a real difference for people with Cerebral Palsy. Early detection is critical for early intervention and this support will allow INFANT to fast track the translation of research and innovation in early brain injury and Cerebral Palsy to clinical care,” said INFANT and UCC Futures Children Director, Professor Geraldine Boylan.

“This generous support will enable us to build on and translate two decades of interdisciplinary research within our INFANT research Centre with a focus on Cerebral Palsy.This exciting development will undoubtedly enhance the very important areas of prevention, early detection and management of Cerebral Palsy. Philanthropy such as this can ensure that our research can be translated into real-world change, improving maternal and child health,” added Professor Helen Whelton, Head of College of Medicine and Health.

The creation of a new Chair at UCC in Early Brain Injury and Cerebral Palsy will build on an existing collaboration between the Cerebral Palsy Foundation and the INFANT Centre on the “Early Detection and Intervention for Cerebral Palsy in Ireland” study. This is a national, multi-centre cohort study led by INFANT and coordinated by In4kids, the HRB Irish Network for Children’s Clinical Trials.

This generous support was facilitated by Alumni and Development UCC and Cork University Foundation. “This funding from the Cerebral Palsy Foundation is a testament to the value of philanthropy in advancing healthcare solutions that benefit everyone,” said Kerry Bryson, CEO of Cork University Foundation.

Cerebral Palsy Foundation Launches Programme of Excellence in Ireland

By |2023-06-29T14:51:24+01:00May 22nd, 2023|

Cerebral Palsy Foundation Launches Programme of Excellence to Revolutionise Cerebral Palsy Care in Ireland

Foundation partnering with University College Cork, Trinity College Dublin, RCSI University of Medicine and Health Sciences, and Children’s Health Ireland to establish Ireland as an international leader for Cerebral Palsy care and research

 

Dublin, Ireland – The Cerebral Palsy Foundation (CPF) has announced the launch of a Programme of Excellence to revolutionise the delivery of cerebral palsy care in Ireland. Through the development of three major clinical and research hubs at University College Cork (UCC), Trinity College Dublin (TCD), and RCSI University of Medicine and Health Sciences, this first-of-its-kind initiative will establish Ireland as an international leader in cerebral palsy care and research. Children’s Health Ireland (CHI) is an implementation partner in the academic healthcare programme.

Cerebral Palsy (CP) is the most common childhood-acquired, lifelong physical disability. Many individuals with CP face significant and unnecessary challenges in their daily lives, including problems with movement, speech, and other body systems.

An estimated 150 babies receive a CP diagnosis in Ireland each year, and an estimated 3,000 children and young people and 9,500 adults are living with CP in Ireland. Early intervention and the right care pathways can make a significant difference in the long-term outcomes and quality of life for people living with CP.

Backed by $12.5 million in philanthropic funding pledged from a group of donors including John and Patrick Collison, this five-year programme will change the trajectory of people’s lives affected by CP in Ireland.

The Programme of Excellence will advance CP care and research across four major pillars:

  • Clinical Implementation Pillar: implementing the best evidence into clinical practice in healthcare settings.
  • Research Pillar: conducting high-quality research programmes and developing an international network of researchers committed to implementation, dissemination, and knowledge transfer.
  • Dissemination and Education Pillar: promoting community education and providing professional education and career pipelines to encourage and develop new clinicians and researchers in the fields of CP clinical care and research.
  • Advocacy and Policy Pillar: identifying and developing stakeholder groups, supporting individuals with CP and their families to drive improved care.

The programme will build on significant strides already made by the CP research community and leading clinicians from around the world. An Expert Steering Committee of cerebral palsy and non-cerebral palsy experts from clinical care, academia, industry, and the CP community will guide the implementation ensuring a multi-disciplinary and multi-stakeholder approach.

Four priority areas of clinical implementation and research have been identified as priority for the initial phase of the programme:

  • Early Detection & Intervention (0-2yrs) led by UCC
  • Musculoskeletal and Orthopaedic Care (children and young people) led by TCD
  • Community-Based Motor Management Services (children, young people, and adults) led by UCC, TCD & RCSI
  • Adult services and support led by RCSI

 

These priority areas will be piloted in regions across Ireland. Once systems have been developed and proven they will be used as models to expand care across the country. The Programme will utilise already established networks including In4Kids, a Health Research Board national paediatric clinical trial network. CPF is committed to expanding this programme through further research funding and philanthropic support. Institutional support from UCC, TCD and RCSI guarantees its continuation beyond the initial five-year period.

 

“Our vision is to make Ireland a world leader in the delivery of Cerebral Palsy care.” said Rachel Byrne, Executive Director of the Cerebral Palsy Foundation. “We want to create a sustainable continued care model for infants through to adults with CP in Ireland led by expert clinicians and researchers. We will leverage our extensive network and international expertise on best practice to help drive the programme through collaboration. We welcome all partners, including the CP Community, academia, industry, and government to join us on this journey.”

 

Lily Collison, whose son Tommy has CP, is a Cerebral Palsy Foundation board member and a long-time advocate for CP care in Ireland. “Cerebral Palsy is the most prevalent childhood acquired physical disability,” she said. “Due to outdated systems and inappropriate interventions, lives are often significantly and unnecessarily compromised. This has long-term social as well as economic implications.” Collison went on to explain that the CP Programme aims to become a world-leader in CP care within five years. “It’s a challenging but achievable goal if we all work hard and smartly together.” she said.

Eilísh Hardiman, Chief Executive of Children’s Health Ireland welcomed this Programme: “Children’s Health Ireland is committed to improving clinical outcomes for infants, children, and young people with Cerebral Palsy. As a partner in paediatric academic health sciences, CHI welcomes collaboration with TCD and UCC to use this philanthropic funding pledge by the CP Foundation to truly make a difference to healthcare, education, research, and innovation in CP care in Ireland.”

Professor Geraldine Boylan, Director of the INFANT Research Centre at University College Cork, expressed excitement for the programme’s potential impact. “We are thrilled to be part of this programme in Ireland and to work with the Cerebral Palsy Foundation, healthcare & research community, and families to make a significant and positive difference in the lives of people with cerebral palsy. Early intervention is critical for people with CP. The earlier we can diagnose and intervene, the better the outcomes for the child and the family.”

Professor Colin Doherty, Head of School of Medicine at Trinity College Dublin said: “This programme provides a rare and unique opportunity for Ireland to become a world leader in cerebral palsy care and treatment. Trinity is working alongside other partners to make real discovery in the development of new diagnostic techniques, new therapies and new pathways of integrated care between the hospital and the community and between childhood, adolescence and adulthood for people with cerebral palsy.”

Professor Cathal Kelly, Vice-Chancellor, RCSI University of Medicine and Health Sciences said: “We are really pleased to be a partner in this important initiative which will have a positive impact on the lives of people with cerebral palsy. As a university wholly focused on health, RCSI is deeply committed to educating the next generation of health care professionals and to research which drives improvements in patient outcomes and quality of life. The RCSI team will now build on the School of Physiotherapy’s track record of leading research and education on cerebral palsy, with a particular focus on adulthood, as part of this new collaboration.”

The Programme will also support the development of a Cerebral Palsy Register in Ireland, enabling the collection of important data to inform research and improve care.

Go to Top